Allogeneic BCMA-targeting CAR T cells in relapsed/refractory multiple myeloma: phase 1 UNIVERSAL trial interim results (vol 29, 422, 2023)
Sham Mailankody,Jeffrey V. Matous,Saurabh Chhabra,Michaela Liedtke,Surbhi Sidana,Olalekan O. Oluwole,Shahbaz Malik,Rajneesh Nath,Faiz Anwer,Jose Carlos Cruz,Myo Htut,Erin E. Karski, Wade Lovelace,Myles Dillon,Eric Butz,Wendy Ying,Arun Balakumaran,Shaji K. Kumar NATURE MEDICINE（2023）
AI 理解论文
溯源树
样例
